June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Quality of life assessment in patients with nasolacrimal duct obstruction after nasolacrimal duct intubation guided by dacryoendoscope
Author Affiliations & Notes
  • Atsushi Shiraishi
    Ophthalmology, Ehime Univ School of Medicine, Toon, Japan
  • Tomoyuki Kamao
    Ophthalmology, Ehime Univ School of Medicine, Toon, Japan
  • Eri Ishikawa
    Ophthalmology, , Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan
  • Naomi Takahashi
    Ophthalmology, Uwajima City Hospital, Uwajima, Ehime, Japan
  • Xiaodong Zheng
    Ophthalmology, Ehime Univ School of Medicine, Toon, Japan
  • Footnotes
    Commercial Relationships   Atsushi Shiraishi, None; Tomoyuki Kamao, None; Eri Ishikawa, None; Naomi Takahashi, None; Xiaodong Zheng, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3843. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Atsushi Shiraishi, Tomoyuki Kamao, Eri Ishikawa, Naomi Takahashi, Xiaodong Zheng; Quality of life assessment in patients with nasolacrimal duct obstruction after nasolacrimal duct intubation guided by dacryoendoscope. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3843.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The outcomes of the subjective symptoms after nasolacrimal duct intubation (NDI) guided by dacryoendoscope have not been well evaluated. To assess the subjective success and quality of life of patients post NDI for nasolacrimal duct obstructions.

Methods : One hundred twenty eight patients diagnosed with unilateral nasolacrimal duct obstruction were treated with NDI guided by dacryoendoscope at Ehime University Hospital from December 2010 to May 2014. The postoperative outcomes were assessed subjectively by Glasgow Benefit Inventory (GBI) as well as ocular specific questionnaire including tearing, discharge, swelling, pain, irritation and blurred vision (scoring the frequency and the degree of the symptoms using a numeric scale 0 to 4) along with objective outcome assessments at 6 months after tube removal.

Results : One hundred twenty four cases out of 128 subjects achieved surgical success (96.9%), and 110 cases out of surgically success 124 cases retained patent after tube removal during the observational periods (88.7%). The mean value for the total GBI score was +38.1, the general subscale score was +43.9, the social subscale score was +27.7, and the physical health score was +24.0. The all 6 ocular specific symptom scores improved significantly postoperatively. When the subjects were divided into 2 groups; Group 1 (presaccal obstruction group), and Group 2 (postsaccal obstruction group), only the postoperative scores of tearing improved (P<0.0001) in Group 1, while the postoperative scores of tearing, discharge, swelling, pain, and blurred vision improved (P<0.0001, P<0.0001, P=0.0002, P=0.0010, P<0.0001, respectively) in Group 2.

Conclusions : The high surgical success rates and improved GBI scores and ocular symptoms scores indicate that NDI guided by dacryoendoscope may be one of the options of treatment other than DCR for lacrimal passage obstruction.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×